Invesque (IVQ) AI Stock Analysis

• Market Cap: C$109.69M
• Dividend Yield: N/A
• Average Volume (3M): 28.42K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.35
• Revenue Growth: -14.85%
• EPS Growth: 79.75%
• Country: CA
• Employees: 1,448
• Sector: Real Estate
• Sector Strength: 55
• Industry: Real Estate - Services
• EPS (TTM): 0.02
• Shares Outstanding: 914,074,400
• 10 Day Avg. Volume: 40,952
• 30 Day Avg. Volume: 28,418
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 40 Underperform
• Price Target: C$0.00 ▼(-100.00% Downside)

Invesque's overall stock score is primarily impacted by its weak financial performance and poor valuation metrics. The technical analysis also indicates bearish momentum. While corporate events show positive strategic moves, they are not enough to offset the financial and technical weaknesses.

Invesque Business Overview & Revenue Model

Company Description

Invesque Inc. (IVQ) is a real estate investment company that focuses on the healthcare and senior living sectors. The company is primarily engaged in owning, acquiring, and investing in a portfolio of healthcare properties across North America, including senior housing communities, skilled nursing facilities, and medical office buildings. Invesque aims to deliver consistent returns to its investors through strategic investments and partnerships within the healthcare real estate market.

How the Company Makes Money

Invesque makes money primarily through leasing its portfolio of healthcare properties to operators and tenants in the senior living and healthcare sectors. The company's revenue model is based on rental income generated from these properties. Invesque enters into long-term lease agreements with healthcare operators, which provide stable and predictable cash flow. The company may also engage in property acquisitions and disposals to optimize its portfolio and maximize returns. Additionally, partnerships with healthcare operators and strategic investments in the sector contribute to the company's earnings by enhancing property value and operational efficiency.

Invesque Financial Statement Overview

Summary

Invesque faces challenges with declining revenues and profitability, high leverage, and a weakening equity position. Although there are improvements in debt management and a slight increase in free cash flow, the overall financial health remains fragile. Strategic actions are needed to stabilize and improve financial performance in the long term.

Income Statement

Invesque's financial performance shows a declining trend in revenue over the past few years, with a notable decrease from 2020 to 2024. The Gross Profit Margin has also been decreasing, indicating potential issues in cost management or pricing strategies. Net Profit Margin remains negative, as the company is struggling with consistent net losses. The absence of EBIT in 2024 and negative EBITDA in 2023 further reflect operational challenges.

Balance Sheet

The company's Debt-to-Equity Ratio is high, indicating significant leverage which poses financial risk, especially in a volatile market. Stockholders' Equity has been decreasing, reflecting a weakening financial position. However, the company has managed to reduce its total liabilities and net debt over the years, which is a positive sign. The Equity Ratio is low, further emphasizing the reliance on debt financing.

Cash Flow

Invesque's cash flow from operations has been positive but insufficient to cover capital expenditures consistently, resulting in low free cash flow. However, there has been a positive trend in Free Cash Flow from 2023 to 2024. The Operating Cash Flow to Net Income Ratio indicates a disparity between reported earnings and actual cash generation, suggesting potential issues in earnings quality.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	162.67M	188.75M	198.03M	210.45M	217.39M
Gross Profit	59.00M	72.41M	95.59M	90.97M	108.39M
EBITDA	24.27M	-18.83M	10.38M	49.13M	-101.52M
Net Income	-36.14M	-99.24M	-42.01M	-28.54M	-184.00M
Balance Sheet
Total Assets	637.22M	828.28M	1.10B	1.30B	1.50B
Cash, Cash Equivalents and Short-Term Investments	18.16M	10.74M	27.58M	19.37M	34.13M
Total Debt	394.84M	588.25M	765.46M	893.75M	1.05B
Total Liabilities	518.05M	681.18M	865.69M	1.01B	1.21B
Stockholders Equity	119.17M	146.59M	231.65M	286.26M	293.33M
Cash Flow
Free Cash Flow	4.40M	217.00K	5.40M	11.11M	13.82M
Operating Cash Flow	9.27M	6.03M	11.91M	18.68M	25.09M
Investing Cash Flow	152.21M	132.05M	137.49M	119.19M	2.98M
Financing Cash Flow	-154.07M	-154.92M	-141.19M	-152.63M	-5.78M

Invesque Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.14, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.72 is Neutral, neither overbought nor oversold. The STOCH value of 23.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:IVQ.

Invesque Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IEI	65 Neutral	C$36.39M	14.46	2.31%	2.08%	-3.35%	―
Sector *	64 Neutral	C$1.99B	4.76	-0.88%	5.24%	2.53%	-62.52%
BRE	59 Neutral	$141.21M	―	4.67%	9.35%	763.30%	-156.55%
SVI	58 Neutral	C$1.71B	―	-23.35%	0.25%	7.94%	-12.23%
MPC	55 Neutral	C$289.22M	15.92	4.66%	1.88%	10.49%	―
IVQ	40 Underperform	C$109.69M	―	-6.06%	―	-14.85%	79.75%

Invesque Corporate Events

Invesque Inc. Advances Asset Disposition Strategy in Q2 2025

Invesque Inc. reported significant progress in its asset disposition strategy during the second quarter of 2025, with several sales transactions completed, including the sale of seniors housing assets in New York, Virginia, Pennsylvania, Texas, Indiana, Arkansas, and Michigan. The company used the proceeds to reduce leverage and streamline its capital stack, expecting further debt repayment progress. The transition of management for certain assets is anticipated to stabilize operations and enhance financial results.

Invesque Inc. Sells Seniors Housing Assets and Optimizes Management

Invesque Inc. has completed the sale of eleven seniors housing assets and transitioned management at four other properties, as part of a strategic move to optimize its portfolio. The transactions, which include the sale of properties in New York, Texas, Indiana, Arkansas, and Michigan, are expected to improve financial performance and allow the company to repay debt and potentially return capital to shareholders, enhancing shareholder value.

Invesque Inc. Shareholders Approve Key Resolutions at Annual Meeting

Invesque Inc. announced the results of its annual and special meeting of shareholders, where all nominated directors were elected with overwhelming support. Additionally, the appointment of KPMG LLP as auditors and special business resolutions, including a Sale Resolution and Reduction in Capital Resolution, were approved by a significant majority. These outcomes reflect strong shareholder confidence and support for Invesque’s strategic direction, potentially enhancing its position in the health care real estate market.

Invesque Completes Strategic Sale of Seniors Housing Assets

Invesque Inc. has completed the sale of 20 seniors housing communities managed by Commonwealth Senior Living and its ownership interests in Commonwealth. The proceeds from the transaction were used to repay associated debts and transaction-related costs. This strategic move marks Invesque’s exit from the Commonwealth business, significantly reducing the company’s leverage and altering its operational focus. The company’s portfolio now consists of 32 assets, with 12 under contract for sale, indicating a shift in strategy to streamline operations and potentially enhance financial stability.

Invesque Inc. Proposes Major Asset Sale and Capital Reduction at Upcoming Shareholder Meeting

Invesque Inc. has announced that at its upcoming annual and special meeting, shareholders will consider a resolution to potentially sell or lease all or substantially all of the company’s assets. This move, if approved, would allow the Board to execute transactions such as asset sales, leases, or mergers at their discretion, although no definitive agreements have been made. Additionally, shareholders will vote on a resolution to reduce capital by up to $183 million to facilitate potential cash distributions following asset divestitures. These decisions could significantly impact Invesque’s operational strategy and financial structure, influencing its market positioning and stakeholder interests.

Invesque Inc. Reports Strategic Asset Sales Amidst First-Quarter Losses

Invesque Inc. reported its first-quarter 2025 results, highlighting significant financial maneuvers including reducing its KeyBank credit facility balance and selling a seniors housing asset in Syracuse, New York. The company has entered into agreements to sell 22 assets for $319.8 million and plans to sell ten memory care communities, aiming to optimize and return value to shareholders. Despite a net loss of $8.943 million, Invesque’s strategic asset sales reflect ongoing interest in the seniors housing sector, potentially strengthening its market position and benefiting stakeholders.